VTE-Related Articles of Interest

VTE National Guidelines, Reviews, Meta-analyses

Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e195S-e226S. Article.

Bump GM, Dandu M, Kaufman SR, et al. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials. J Hosp Med. 2009;4:289-297. Abstract.

Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S.  Abstract.

Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007;146:278-288.  Abstract.

Wein L, Wein S, Haas SJ, et al. Pharmacologic venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1476-1486.  No abstract available.

Pharmacologic VTE Prophylaxis Trials

Phung OJ, Kahn SR, Cook DJ, Murad MH. Dosing frequency of unfractionated heparin thromboprophylaxis. A meta-analysis. Chest. 2011;140:374-381.  Abstract.

Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332:325-9.  Abstract.

Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of daltaparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874-879.  Abstract.

Kleber F, Witt C, Vogel G, et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J. 2003;145:614-21.  Abstract.

Samama MM, Cohen AT, Darmon J, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 1999;341:793-800.  Abstract.

VTE Risk Assessment

Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med. 2011;6:202-209.  Abstract.

Maynard GA, Morris TA, Jenkins IH, et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med. 2010;5:10-18.  Abstract.

Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70-78. Abstract.

VTE Prophylaxis Compliance

Anderson FA, Goldhaber SZ, Tapson VF et al. Improving practices in US hospitals to prevent venous thromboembolism: Lessons from ENDORSE. Am J Med. 2010;123:1099-1106.  Abstract.

Rothberg MB, Lahti M, Pekow PS, et al. Venous thromboembolism prophylaxis among medical patients at US hospitals. J Gen Intern Med. 2010:25:489-94.  Abstract.

Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969-77. AbVTE stract.

VTE Bleeding Risk

Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients. Chest. 2011;139:69-79. Abstract.